trending Market Intelligence /marketintelligence/en/news-insights/trending/ohlglyr8jbqcrr-0rxv_wg2 content esgSubNav
In This List

OBJ chairman steps down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


OBJ chairman steps down

Australia's OBJ Ltd. said Chairman Glyn Denison stepped down from the board Feb. 2.

Denison served on the company's board for 12 years, and first stated his intention to retire in August 2017.

OBJ develops drug and ingredient delivery technologies for pharmaceutical, healthcare, cosmetic and homecare applications.